Publications and communications of Vincent LAMBERT

Widart, J., Beauvois, V., Lambert, V., Maesen, P., & Hubert, P. (2023). Rapport d'activités RQLab - Année 2022.

Arslan, D., Schoumacher, M., Dilly, S., Elmoualij, B., Zorzi, D., Quatresooz, P., Lambert, V., Noël, A., Pirotte, B., & De Tullio, P. (2023). Design, Synthesis, and Evaluation of Novel Pyruvate Dehydrogenase Kinase Inhibitors. Medicinal Chemistry, 19 (3), 276-296. doi:10.2174/1573406418666220819102627

Widart, J., Beauvois, V., LAMBERT, V., Maesen, P., & Hubert, P. (2022). Rapport d'activités RQLab - Année 2021. autre.

Schoumacher, M., Lambert, V., Govaerts Bernadette, Rakic, J.-M., Noël, A., & De Tullio, P. (2022). From cohort study to the “real life” in patient’s follow-up and personalized medicine using NMR- based clinical metabolomics; results, issues, problems and prospects: the case of neovascular Age-related Macular Degeneration (nAMD) [Poster presentation]. Metabolomics 2022 Valence, valence, Spain.

Roblain, Q., Louis, T., Yip, C., Baudin, L., Struman, I., Caolo, V., LAMBERT, V., Lecomte, J.* , Noël, A.* , & Heymans, S.*. (2021). Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization. Aging, 13. doi:10.18632/aging.203035

LAMBERT, V.* , hansen, S.* , Schoumacher, M.* , Lecomte, J., Leenders, J., Hubert, P., Herfs, M., Blacher, S., Carnet, O., Yip, C., BLAISE, P., DUCHATEAU, E., LOCHT, B., THYS, M., CAVALIER, E., GOTHOT, A., Govaerts, B., RAKIC, J.-M., Noël, A.* , & De Tullio, P.*. (2020). Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics. Journal of Molecular Medicine. doi:10.1007/s00109-020-01994-9

LAMBERT, V., MARECHAL, A., MANGIONE, J., Rakic, J.-M., & DUCHESNE, B. (17 January 2020). Decontamination of whole donor eye globes with a commercial antibiotic cocktail medical device [Poster presentation]. XXXII Annual Meeting of the European Eye Bank Association EEBA, Hannover, Germany.

Arslan, D., LAMBERT, V., Noël, A., Pirotte, B., De Tullio, P., Zorzi, D. (Other coll.), & Hansen, S. (Other coll.). (11 December 2019). From Metabolomics Study of Age Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase (PDK) Inhibitors [Poster presentation]. 2nd CIRM-day.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (11 December 2019). New Insight into exudative Age-related Macular Degeneration (AMD): A Metabolomics Approach [Paper presentation]. nd CIRM Day, Liège, Belgium.

Schoumacher, M., LAMBERT, V., Hansen, S., leenders, J., govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (23 June 2019). New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and patients follow-up [Poster presentation]. Metabolomics 2019, The Hague, Netherlands.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (23 May 2019). New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and patients follow-up [Paper presentation]. 12èmes journées RFMF, Clermont-Ferrand, France.

Arslan, D., LAMBERT, V., Noël, A., Pirotte, B., De Tullio, P., Schoumacher, M. (Other coll.), Hansen, S. (Other coll.), & Elmoualij, B. (Other coll.). (19 December 2018). From Metabolomics Study of Age Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase (PDK) Inhibitors [Paper presentation]. 1st CIRM DAY.

Kok, M., Nix, C., Nys, G., De Tullio, P., Lecomte, J., LAMBERT, V., & Fillet, M. (19 December 2018). Fluxomics of AMD using mass spectrometry from 10 µL of mice whole blood; investigation of DCA treatment [Poster presentation]. First CIRM Day.

Arslan, D., LAMBERT, V., Elmoualij, B., Noël, A., Pirotte, B., De Tullio, P., Schoumacher, M. (Other coll.), & Hansen, S. (Other coll.). (23 November 2018). From Metabolomics Study of Age Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase Inhibitors (PDK) [Poster presentation]. MedChem 2018 New Avenues in Kinase Drug Discovery: a Bright Future ?.

LAMBERT, V., Schoumacher, M., Lecomte, J., Arslan, D., Leenders, J., Govaerts, B., RAKIC, J.-M., Noël, A., & De Tullio, P. (19 September 2018). Metabolomics for the discovery of new therapeutic approach and personalized medicine: the case of exudative Age-related Macular Degeneration [Paper presentation]. Benelux metabolomics Days, Netherlands.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (19 September 2018). NMR-based metabolomics study of Age-related Macular Degeneration (AMD): patient follow-up and new target discovery [Poster presentation]. Benelux metabolomics Days, Netherlands.

De Vos, D., Ectors, N., Giet, O., Glorieux, S., Guns, J., Janssens, H., Janssens, R., LAMBERT, V., THONON, F., Vansteenbrugge, A., & Verbeken, G. (2018). CSS 9453 Qualification des salles propres et monitoring des processus aseptiques dans les banques de matériel corporel humain, les structures intermédiaires et les établissements de production. Conseil Supérieur de la Santé.

Schoumacher, M., LAMBERT, V., Leenders, J., Roblain, Q., govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (05 July 2018). NMR-based Metabolomics for New Target Discovery and Personalized Medicine: Application to Age-Related Macular Degeneration (AMD) [Paper presentation]. EUROMAR (European Magnetic Resonance Meeting), Nantes, France.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (24 June 2018). NMR-Based metabolomics study of Age-related Macular Degeneration (AMD): from pre-clinic model to new target discovery [Poster presentation]. Metabolomics 2017, Seattle, United States.

Schoumacher, M., LAMBERT, V., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (23 May 2018). New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and subclass analysis [Poster presentation]. 11e JS du RFMF, Liege, Belgium.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (02 October 2017). New translational metabolomics exploration of age-related macular degeneration: from patients to functional implication of lactate [Paper presentation]. SMMAP 2017, Paris, France.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (02 October 2017). New Translational Metabolomics Exploration of Age-Related Macular Degeneration: From Patients to Functional Implication of Lactate [Poster presentation]. SMMAP 2017, Paris, France.

Arslan, D., Schoumacher, M., Pirotte, B., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (14 September 2017). From Metabolomics Study of Age-Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase Inhibitors (PDK) [Poster presentation]. 31éme ournée Franco-Belge de Pharmacochimie, SPA, Belgium.

García Caballero, M., Van De Velde, M., Blacher, S., LAMBERT, V., BALSAT, C., Erpicum, C., Durré, T., Kridelka, F., & Noël, A. (2017). Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay. Scientific Reports, 7, 41494. doi:10.1038/srep41494

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (27 June 2016). New Insight into exudative Age-related Macular Degeneration (AMD): A Metabolomics Approach [Poster presentation]. Metabolomics 2016, Dublin, Ireland.

Arslan, D., Schoumacher, M., Pirotte, B., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (May 2016). From Metabolomics Study of Age-Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase Inhibitors (PDK) [Poster presentation]. JFB 2016 : 30èmes Journées Franco-Belges de Pharmacochimie, Amboise, France.

Schoumacher, M., De Tullio, P., LAMBERT, V. (Other coll.), Hansen, S. (Other coll.), Leenders, J. (Other coll.), Govaerts, B. (Other coll.), Pirotte, B. (Other coll.), RAKIC, J.-M. (Other coll.), & Noël, A. (Other coll.). (May 2016). From Metabolomics to Identification of a new therapeutic approach for Age-Related Macular Degeneration (AMD) [Poster presentation]. JFB 2016 : 30èmes Journées Franco-Belges de Pharmacochimie, Amboise, France.

Widart, J., Beauvois, V., Dumont, F., LASRI, S., LAMBERT, V., PIRSON, L., & Hubert, P. (2016). Réseau Qualité des Laboratoire de l'ULg - Rapport d'activité Février 2016.

Arslan, D., Schoumacher, M., Pirotte, B., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (12 November 2015). FROM METABOLOMICS STUDY OF AGE RELATED MACULAR DEGENERATION (AMD) TO THE DEVELOPMENT OF NEW PDK INHIBITORS [Poster presentation]. International Gazi Pharma Symposium Series, Antalya, Turkey.

Schoumacher, M., Arslan, D., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), Noël, A. (Other coll.), & Pirotte, B. (Other coll.). (June 2015). From Metabolic Study of Age-Related Macular Degeneration (AMD) to Development of New PDH Kinase Inhibitors [Poster presentation]. 29ème Journées Franco-Belge de Pharmacochimie, Spa, Belgium.

Arslan, D., Pirotte, B., De Tullio, P., Charif, M. (Other coll.), Dilly, S. (Other coll.), Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (09 September 2014). AGE-RELATED MACULAR DEGENERATION (AMD): FROM METABOLOMICS APPROACH TO THE INHIBITION OF PDK AS A NEW THERAPEUTIC TARGET [Poster presentation]. XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC 2014), Lisbonne, Portugal.

LAMBERT, V., Dufour, G., Chiap, P., Evrard, B., Noël, A., Pirotte, B., & De Tullio, P. (23 June 2014). NMR in the Pharmaceutical and Biomedical areas for identification and quantification of drugs and metabolomics applications [Paper presentation]. Drug Analysis 2014, Liège, Belgium.

Arslan, D., Pirotte, B., De Tullio, P., Charif, M. (Other coll.), Dilly, S. (Other coll.), Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (June 2014). Inhibition of PDH Kinase as a new therapeutic target for Age-related Macular Degeneration (AMD) [Poster presentation]. 28e Journées franco-belges de Pharmacochimie, Communauté de Metz Métropole, France.

Matheus, N., Hansen, S., Rozet, E., Peixoto, P., Maquoi, E., LAMBERT, V., Noël, A., Frederich, M., Mottet, D., & De Tullio, P. (January 2014). An Easy, Convenient Cell and Tissue Extraction Protocol for Nuclear Magnetic Resonance Metabolomics. Phytochemical Analysis, 25, 342-349. doi:10.1002/pca.2498

LAMBERT, V., De Tullio, P., & Hansen, S. (04 October 2013). Age-related Macular Degeneration Study: A Metabolomics Approach [Paper presentation]. GIGA Cancer Seminar.

Arslan, D., Dilly, S., LAMBERT, V., Hansen, S., RAKIC, J.-M., Noël, A., Govaerts, B., Pirotte, B., & De Tullio, P. (06 June 2013). Age-related Macular Degeneration (AMD): from Metabolomics approach to the inhibition of PDH Kinase as a new therapeutic target [Poster presentation]. 27e Journées franco-belges de Pharmacochimie, Lille, France.

LAMBERT, V., Hansen, S., Rousseau, R., Govaerts, B., Pirotte, B., RAKIC, J.-M., Noël, A., & De Tullio, P. (23 May 2013). Age-related Macular Degeneration Study: A Metabolomics Approach [Paper presentation]. First Belgian-Netherlands Joint Symposium on Metabolomics: Transational approaches in Metabolomics, Spa, Belgium.

Detry, B., Blacher, S., Erpicum, C., Paupert, J., Maertens, L., Maillard, C., Munaut, C., Sounni, N. E., LAMBERT, V., Foidart, J.-M., Rakic, J.-M., Cataldo, D., & Noël, A. (2013). Sunitinib inhibits inflammatory corneal lymphangiogenesis. Investigative Ophthalmology and Visual Science, 54 (5), 3082-93. doi:10.1167/iovs.12-10856

Halkein, J., Tabruyn, S. P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Thiry, M., Sliwa, K., Noël, A., Martial, J., Hilfiker-Kleiner, D., & Struman, I. (2013). MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. Journal of Clinical Investigation, 123 (5), 2143-54. doi:10.1172/JCI64365

LAMBERT, V., Lecomte, J., Hansen, S., Blacher, S., Alvarez Gonzalez, M.-L., Struman, I., Sounni, N. E., Rozet, E., De Tullio, P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (2013). Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nature Protocols, 8 (11), 2197-2211. doi:10.1038/nprot.2013.135

Detry, B.* , Erpicum, C.* , Paupert, J.* , Blacher, S., Maillard, C., Bruyère, F., Pendeville, H., Remacle, T., LAMBERT, V., Balsat, C., Ormenese, S., Lamaye, F., Janssens, E., Moons, L., CATALDO, D., Kridelka, F., Carmeliet, P., Thiry, M., Foidart, J.-M., ... Noël, A. (24 May 2012). Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase. Blood, 119 (21), 5048-56. doi:10.1182/blood-2011-12-400267

Halkein, J., Tabruyn, S., Haghikia, A., Hoch, M., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Sliwa, K., Noël, A., Martial, J., Hilfiker-Kleiner, D., & Struman, I. (19 May 2012). MicroRNA-146a, a downstream effector of 16K prolactin, is a therapeutic target and a specific biomarker for peripartum cardiomyopathy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.

Halkein, J., Tabruyn, S., Haghikia, A., Hoch, M., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Sliwa, K., Noël, A., Martial, J., Hilfiker-Kleiner, D., & Struman, I. (April 2012). MicroRNA-146a is a causative factor and a specific biomarker for peripartum cardiomyopathy [Poster presentation]. Biomedica, Liège, Belgium.

Halkein, J., Tabruyn, S., Haghikia, A., Castermans, K., Malvaux, L., Lambert, V., Labidi, S., Sliwa, K., Noël, A., Martial, J., Hilfiker-Kleiner, D., & Struman, I. (January 2012). MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy [Poster presentation]. Keystone symposia on Angiogenesis advances in basic sciences and therapeutic applications, Snowbird Resort, Snowbird, Utah, United States.

Detry, B., Blacher, S., Erpicum, C., Paupert, J., Maillard, C., Sounni, N. E., LAMBERT, V., & Noël, A. (October 2011). Inhibition of Experimental Corneal Neovascularization by Sunitinib Administration [Poster presentation]. 3ème congrés de la Société Française d'Angiogenèse.

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Labidi, S., Hilfiker-Kleiner, D., Martial, J., Tabruyn, S., & Struman, I. (March 2011). MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy [Poster presentation]. IVth International Meeting on Angiogenesis, Amsterdam, Netherlands.

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Noël, A., Martial, J., Tabruyn, S., & Struman, I. (March 2011). Mir-146a : A new angiostatic miRNA with tumor-suppressive properties [Poster presentation]. IVth International Meeting on Angiogenesis, Amsterdam, Netherlands.

Halkein, J., Bovy, N., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Martial, J., Tabruyn, S., & Struman, I. (February 2011). MiR-146a: an angiostatic miRNA with tumor-suppressive properties [Poster presentation]. Keystone Symposia : MicroRNAs and Non-Coding RNAs and Cancer, Banff, Alberta, Canada.

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Labidi, S., Hilfiker-Kleiner, D., Martial, J., Tabruyn, S., & Struman, I. (February 2011). MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy [Poster presentation]. Keystone Symposia : MicroRNAs and Human Disease, Banff, Alberta, Canada.

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., Lambert, V., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (February 2011). microRNA-21 Exhibits Anti-Angiogenic Function by Targeting RhoB Expression in Endothelial Cells [Poster presentation]. Keystone Symposia : MicroRNAs and Non-Coding RNAs and Cancer, Banff, Alberta, Canada.

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Labidi, S., Hilfiker-Kleiner, D., Martial, J., Tabruyn, S., & Struman, I. (January 2011). MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy [Poster presentation]. Giga-Day Symposia, Liège, Belgium.

Lecomte, J., Louis, K., Detry, B., Blacher, S., Lambert, V., Bekaert, S., Munaut, C., Paupert, J., Blaise, P., Foidart, J.-M., Rakic, J.-M., Krane, S. M., & Noël, A. (2011). Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cellular and Molecular Life Sciences, 68, 677-686. doi:10.1007/s00018-010-0476-6

Pirotte, S., Lamour, V., Lambert, V., Alvarez Gonzalez, M.-L., Ormenese, S., Noël, A., Mottet, D., Castronovo, V., & Bellahcene, A. (2011). Dentin Matrix Protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation. Blood, 117 (8), 2515-26. doi:10.1182/blood-2010-08-298810

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., LAMBERT, V., Alvarez Gonzalez, M.-L., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (2011). MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells. PLoS ONE, 6 (2), 16979. doi:10.1371/journal.pone.0016979

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Noël, A., Martial, J., Tabruyn, S., & Struman, I. (October 2010). Mir-146a : A new angiostatic miRNA with tumor-suppressive properties [Poster presentation]. Frontiers in Tumor Progression, Madrid, Spain.

Malvaux, L., Pendeville, H., Sabatel, C., Lambert, V., Nivelles, O., Martial, J., & Struman, I. (21 May 2010). Involvement of miR-125b in in vitro and in vivo angiogenesis [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., Lambert, V., Martial, J., & Struman, I. (May 2010). Study of the role of miR-21 in the regulation of angiogenesis [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.

Malvaux, L., Pendeville, H., Sabatel, C., Lambert, V., Nivelles, O., Martial, J., & Struman, I. (March 2010). Involvement of miR-125b in in vitro and in vivo angiogenesis [Poster presentation]. Biomedica, Aachen, Germany.

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., Lambert, V., Martial, J., & Struman, I. (March 2010). Study of the role of miR-21 in the regulation of angiogenesis [Poster presentation]. Biomedica, Aachen, Germany.

Bruyere, F.* , Melen-Lamalle, L.* , Blacher, S., Detry, B., Masset, A., Lecomte, J., Lambert, V., Maillard, C., Hoyer-Hansen, G., Lund, L. R., Foidart, J.-M., & Noël, A. (2010). Does plasminogen activator inhibitor-1 drive lymphangiogenesis? PLoS ONE, 5 (3), 9653. doi:10.1371/journal.pone.0009653

Dubail, J., Kesteloot, F., Deroanne, C., Motte, P., Lambert, V., Rakic, J.-M., Lapiere, C., Nusgens, B., & Colige, A. (2010). ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cellular and Molecular Life Sciences. doi:10.1007/s00018-010-0431-6

Hemmer, M., Kempen, I., De Tullio, P., Frankenne, F., Lambert, V., Blacher, S., Bueb, J.-L., Foidart, J.-M., Noël, A., Tschirhart, E., & Pirotte, B. (2010). New Biological Investigations on 3-Bromophenyl 6-Acetoxymethyl-2-oxo-2H-1-Benzopyran-3-Carboxylate as Anti-angiogenic Agent. Drug Development Research, 71, 1-10. doi:10.1002/ddr.20364

Van de Veire, S., Stalmans, I., Heindryckx, F., Oura, H., Tijeras-Raballand, A., Schmidt, T., Loges, S., Albrecht, I., Jonckx, B., Vinckier, S., Van Steenkiste, C., Tugues, S., Rolny, C., De Mol, M., Dettori, D., Hainaud, P., Coenegrachts, L., Contreres, J.-O., Van Bergen, T., ... Carmeliet, P. (2010). Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell, 141 (1), 178-90. doi:10.1016/j.cell.2010.02.039

Lambert, V., Frederich, M., Rousseau, R., Detry, B., Peulen, O., Rakic, J.-M., Noël, A., Pirotte, B., Govaert, B., & De Tullio, P. (August 2008). 1H NMR metabolomic approach of the laser-induced choroidal neovascularization in mice [Poster presentation]. 20th International Symposium on Medicinal Chemistry, Vienne, Austria.

Hemmer, M., Kempen, I., De Tullio, P., Haan, , Lambert, V., Noël, A., Foidart, J.-M., Bueb, J. L., Tschirhart, E., & Pirotte, B. (May 2008). New biological investigations on the anti-angiogenic agent 3-bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate: in search of its original mechanism of action [Poster presentation]. 22èmes Journées Franco-Belges de Pharmacochimie, Caen, France.

Kuiper, E. J., Roestenberg, P., Ehlken, C., Lambert, V., van Treslong-de Groot, H. B., Lyons, K. M., Agostini, H.-J. T., Rakic, J.-M., Klaassen, I., Van Noorden, C. J. F., Goldschmeding, R., & Schlingemann, R. O. (November 2007). Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. Journal of Histochemistry and Cytochemistry, 55 (11), 1139-1147. doi:10.1369/jhc.7A7258.2007

Noël, A., Jost, M., Lambert, V., Lecomte, J., & Rakic, J.-M. (August 2007). Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Trends in Molecular Medicine, 13 (8), 345-352. doi:10.1016/j.molmed.2007.06.005

Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2007). Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. American Journal of Pathology, 171 (4), 1369-80. doi:10.2353/ajpath.2007.070074

van Geest, R. J., Kuiper, E. J., Ehlken, C., Lambert, V., Bloys, H., Lyons, K. M., Agostini, H. J. T., Rakic, J.-M., Klaassen, I., van Noorden, C. J. F., Goldschmeding, R., & Schlingemann, R. O. (2007). Connective tissue growth factor (CTGF) is not involved in angiogenesis in knock out mouse models. European Journal of Ophthalmology, 17 (3, MAY-JUN), 476.

Jost, M., Maillard, C., Lambert, V., Tjwa, M., Blaise, P., Lecomte, J., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization. Acta Clinica Belgica, 61 (2, MAR-APR), 87.

Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., RAKIC, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type 1 (PAI-1) controls bone marrow-dependent and independent vascularization [Poster presentation]. Meeting ABEC/BVSK.

Lambert, V. (2005). Rôle des protéinases et de leurs inhibiteurs dans les formes associées à une néovascularisation anormale sous-rétinienne. Caractérisation par l’étude de modèles animaux transgéniques et développements thérapeutiques [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/30882

Kempen, I., Lambert, V., Melen, L., Noël, A., Foidart, J.-M., & Pirotte, B. (May 2005). Evaluation pharmacologique du 6-acétoxyméthyl-2-oxo-2H-1-benzopyrane-3-carboxylate de 3-bromophényle en tant qu’agent anti-angiogénique [Poster presentation]. 19èmes Journées Franco-Belges de Pharmacochimie, Liège, Belgium.

Dubail, J., Kesteloot, F., Motte, P., Lambert, V., Rakic, J.-M., Lapiere, C. M., Nusgens, B., & Colige, A. (2005). ADAMTS-2, a metalloproteinase containing a disintegrin domain and thrombospondin type I repeats, a new regulator of angiogenesis. Journal of Vascular Research, 42 (Suppl. 2), 76.

Dubail, J., Kesteloot, F., Motte, P., Lambert, V., Rakic, J.-M., Lapière, C. M., Nusgens, B., & Colige, A. (2004). Effect of ADAMTS-2, a metalloproteinase containing a disintegrin domain and thrombospondin type I repeats, during angiogenesis in vitro and in vivo. Angiogenesis, 7 (2), 172.

Rakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Munaut, C., & Noël, A. (July 2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Investigative Ophthalmology and Visual Science, 44 (7), 3186-3193. doi:10.1167/iovs.02-1092

Lambert, V., Munaut, C., Carmeliet, P., Gerard, R. D., Declerck, P. J., Gils, A., Claes, C., Foidart, J.-M., Rakic, J.-M., & Noël, A. (June 2003). Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type 1: Implications for clinical trials. Investigative Ophthalmology and Visual Science, 44 (6), 2791-2797. doi:10.1167/iovs.02-1179

Lambert, V., Wielockx, B., Munaut, C., Werb, Z., Baker, A., Foidart, J.-M., Noël, A., & Rakic, J.-M. (May 2003). Severe inhibition of choroidal neovascularization in mice with a combined deficiency of MMP-2 and MMP-9 genes. Investigative Ophthalmology and Visual Science, 44 (Suppl. 2), 410.

Rakic, J.-M., Lambert, V., Munaut, C., Bajou, K., Peyrollier, K., Alvarez Gonzalez, M.-L., Carmeliet, P., Foidart, J.-M., & Noël, A. (April 2003). Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization. Investigative Ophthalmology and Visual Science, 44 (4), 1732-1739. doi:10.1167/iovs.02-0809

Rakic, J.-M., Maillard, C., Jost, M., Bajou, K., Masson, V., Devy, L., Lambert, V., Foidart, J.-M., & Noël, A. (March 2003). Role of plasminogen activator-plasmin system in tumor angiogenesis. Cellular and Molecular Life Sciences, 60 (3), 463-473. doi:10.1007/s000180300039

Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Itoh, T., Werb, Z., Baker, A., Krell, H. W., Foidart, J.-M., Rakic, J.-M., libert, C., & Noël, A. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB Journal, 17 (15), 2290-2292. doi:10.1096/fj.03-0113fje

Rakic, J.-M., Lambert, V., Deprez, M., Foidart, J.-M., Noël, A., & Munaut, C. (2003). Estrogens reduce the expression of YKL-40 in the retina: Implications for eye and joint diseases. Investigative Ophthalmology and Visual Science, 44 (4), 1740-1746. doi:10.1167/iovs.02-0775

Fraikin, N., Munaut, C., Lambert, V., Frankenne, F., Foidart, J.-M., Rompen, E., & Noël, A. (December 2002). Presence of alpha and beta estrogen receptors in human gingiva. Journal of Dental Research, 81 (Sp. Iss. B), 239-B239.

Lambert, V., Munaut, C., Jost, M., Werb, Z., Foidart, J.-M., Rakic, J.-M., & Noël, A. (October 2002). Matrix metalloproteinase-9 contributes to choroidal neovascularization. American Journal of Pathology, 161 (4), 1247-1253. doi:10.1016/S0002-9440(10)64401-X

Lambert, V., Thierens, H., Monsieurs, M., Roncancio, C., & Laurent, C. (June 2001). Translocation Frequencies Measured in Patients One Year after Radioactive Iodine Therapy for Thyrotoxicosis. International Journal of Radiation Biology, 77 (6), 679-85. doi:10.1080/09553000110042127

Lambert, V., Munaut, C., Frankenne, F., Bajou, K., Gerard, R., Carmeliet, P., Defresne, M.-P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (April 2001). Influence of Plasminogen Activator Inhibitor Type 1 on Choroidal Neovascularization. FASEB Journal, 15 (6), 1021-7. doi:10.1096/fj.00-0393com

Munaut, C., Lambert, V., Noël, A., Frankenne, F., Deprez, M., Foidart, J.-M., & Rakic, J.-M. (2001). Presence of Oestrogen Receptor Type Beta in Human Retina. British Journal of Ophthalmology, 85 (7), 877-82. doi:10.1136/bjo.85.7.877

Noël, A., Bajou, K., Masson, V., Frankenne, F., Rakic, J.-M., Lambert, V., Carmeliet, P., & Foidart, J.-M. (1999). Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1. Fibrinolysis and Proteolysis, 13 (6), 220-225. doi:10.1054/fipr.2000.0043

Thierens, H., Vral, A., de Ridder, L., Touil, N., Kirsch-Volders, M., LAMBERT, V., & Laurent, C. (1999). Inter-laboratory comparison of cytogenetic endpoints for the biomonitoring of radiological workers. International Journal of Radiation Biology, 75 (1), 23-34. doi:10.1080/095530099140771

Jacquet, M., LAMBERT, V., Todaro, A., & Kremers, P. (February 1997). Mitogen-activated lymphocytes: a good model for characterising lung CYP1A1 inducibility. European Journal of Epidemiology, 13 (2), 177-183. doi:10.1023/A:1007354532547

Hugla, J. L., Goffinet, G., Kremers, P., Dubois, M., Lambert, V., Stouvenakers, N., & Thomé, J.-P. (July 1996). Ultrastructural Modifications in Cultured Fetal Quail Hepatocytes Exposed to Pesticides and Pcbs. Ecotoxicology and Environmental Safety, 34 (2), 145-55. doi:10.1006/eesa.1996.0056

Jacquet, M., LAMBERT, V., BAUDOUX, E., Muller, M., Kremers, P., & Gielen, J. (April 1996). Correlation between P450 CYP1A1 Indelibility, MsPI Genotype and Lung Cancer Incidence. European Journal of Cancer, 32A (10), 1701-1706.